Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from Korea.

Clinical lymphoma, myeloma & leukemia - 1 Feb 2012

Lee Ho Sup, Park Lee Chun, Lee Eun Mi, Lee Shin Jun, Shin Seong Hoon, Im Hana, Do Kil Min, Kim Eeon Jin, Ye Byeong Jin, Song Moo Kon, Kim Sung-Hyun, Lee Sang Min, Lee Won Sik, Kim Yang Soo

Abstract excerpt

BACKGROUND: Essential thrombocythemia (ET) is classified as a Philadelphia chromosome-negative classic myeloproliferative neoplasm. ET is a clonal stem cell disorder that is often associated with JAK2 mutations and shares phenotypic and pathogenetic similarities with other myeloproliferative neoplasms. Hemorrhagic complications and arterial and venous thrombosis are common in patients with ET. The aim of this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Hemorrhage

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Incidence

Share to Janus Kinase 2

Share to Multivariate Analysis

Share to Republic of Korea

Share to Thrombocythemia, Essential

Share to Thrombosis

Source

Identifiers

PMID: 22088920
DOI: 10.1016/j.clml.2011.10.002

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from Korea.PMID 22088920Read ↗

Clinico-hematological profile and thrombotic/hemorrhagic events in 150 chinese patients with essential thrombocythemia.Semantic proximity Read ↗

Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation.Semantic proximity Read ↗

The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.Semantic proximity Read ↗

Essential Thrombocythemia: One-Center Data in a Changing Disease.Semantic proximity Read ↗

The new WHO classification for essential thrombocythemia calls for revision of available evidences.Semantic proximity Read ↗

New advances in the pathogenesis and therapy of essential thrombocythemia.Semantic proximity Read ↗

The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.Semantic proximity Read ↗

Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.Semantic proximity Read ↗

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.Semantic proximity Read ↗

Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.Semantic proximity Read ↗

[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease].Semantic proximity Read ↗

Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.